Hope trumpets quality of first US approved sodium nitrite injection for cyanide poisoning
This article was originally published in Scrip
Executive Summary
The US FDA has approved Hope Pharmaceuticals' sodium nitrite injection for treating life-threatening cyanide poisoning. The firm says it is the first sodium nitrite injection to be FDA-approved. In a statement, Hope draws attention to the importance of high-quality medicines for very sick patients and says that doctors should choose an approved product whenever possible. Sodium nitrite drugs have been available in the US without approval for some time and conform to industry specifications published before 1970. Hope's injection, intended for sequential use with sodium thiosulphate, meets more stringent requirements, including recent advances in quality including limits on bacterial, chemical, degradation and processing impurities.
You may also be interested in...
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
German HTA Queries Polivy Benefits Amid Lack Of Evidence
Roche’s lymphoma drug Polivy could face pricing challenges in Germany as it undergoes a full benefit assessment.
Germany Confirms No Reimbursement Status For ‘Lifestyle’ Drug Wegovy
In Germany Novo Nordisk’s obesity drug Wegovy will remain excluded from reimbursement for obesity, unlike Rhythm’s Imcivree.